Skip to main content
Loading...
Menu social network
LinkedIn
Facebook
X
Youtube
Menu top
Assistance
User account menu
Log in
Main navigation
Home
Programme
Download the app
App
Download the app
App
Menu
Login
Close
Main navigation mobile
Home
Programme
Menu top
Assistance
Menu social network
LinkedIn
Facebook
X
Youtube
18 results
D2.480 - Features of the molecular sensitization profile in children with autism spectrum disorder
D2.485 - Comprehensive Understanding of the Characteristics of Pediatric Pollen Allergy Patients
D2.486 - Levels of house dust mite in dust settlements are associated with risk for allergic rhinitis in children
D2.479 - The bullous pemphigoid in a baby
D2.481 - Severe obstructive syndrome in children with bronchopulmonary malformations
D2.488 - Functional confirmation of exercise-induced bronchoconstriction in children: A three-year retrospective study
D3.213 - Sustained effectiveness of the 300 IR house dust mite sublingual tablet over 2 treatment years in a real-world data setting – results of a non-interventional study
D3.198 - Challenges of using clinical scores as primary endpoints in allergology trials
D3.199 - Severe systemic allergic reaction following violation of elimination diet in a patient with sensitization despite achieved remission on allergen-specific immunotherapy
D3.200 - Broad profile of olive pollen sensitisation as a key factor in immunotherapy failure
D3.201 - Subcutaneous immunotherapy with a depigmented cat allergoid is safe in patients with cat allergy and beneficial for mental health in adolescents
D3.205 - Two-year Outcomes of Multiple Low-Dose Oral Immunotherapies for combination of Tree Nuts or Peanut for Severe Allergy Patients
D3.207 - Symptomatology and Sensitization Profiles of Patients Undergoing Subcutaneous Immunotherapy for Aeroallergens in Greece
D3.209 - Subcutaneous Allergen Immunotherapy in Children: Frequency of Local and Systemic Adverse Reactions and Associated Risk Factors
- D3.540 - Sources of IL-13 in Acute Versus Chronic Models of Eosinophilic Esophagitis
- D3.539 - Evaluation of Treatment Selection and Response in Patients with Eosinophilic Esophagitis Based on Clinical Findings and Allergy Testing
- D3.541 - Who takes the patient with eosinophilic esophagitis (EoE) and acute laryngeal edema?
- D3.542 - Prevalence of sensitization to panallergens and IgG4 profiles against specific foods in patients with allergic-phenotype eosinophilic esophagitis
Download the app
The congress at your fingertips
Available on
Download